Prevention Regimen for Effectively Avoiding Second Strokes - PRoFESS


PRoFESS was a double-blinded randomized international clinical trial where patients with a recent (within 3 months) non-cardioembolic ischemic stroke were randomized in a 2 × 2 factorial design to: 1) either fixed combination of low-dose aspirin 25 mg and extended-release dipyridamole 200 mg twice daily or clopidogrel 75 mg once daily, and 2) telmisartan 80 mg daily or placebo.